M378 exhibits anti-inflammatory activities through NLRP3 signaling pathway
- 11 September 2022
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 933, 175261
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (J1103507, J1210025)
- Priority Academic Program Development of Jiangsu Higher Education Institutions
This publication has 24 references indexed in Scilit:
- TRPM2 links oxidative stress to NLRP3 inflammasome activationNature Communications, 2013
- Treating inflammation by blocking interleukin-1 in a broad spectrum of diseasesNature Reviews Drug Discovery, 2012
- Gastrointestinal-Sparing Effects of Novel NSAIDs in Rats with Compromised Mucosal DefencePLOS ONE, 2012
- Markedly reduced toxicity of a hydrogen sulphide‐releasing derivative of naproxen (ATB‐346)British Journal of Pharmacology, 2010
- Targeted Expression of Uncoupling Protein 2 to Mouse Liver Increases the Susceptibility to Lipopolysaccharide/Galactosamine-Induced Acute Liver Injury†Hepatology, 2009
- Immunological and Inflammatory Functions of the Interleukin-1 FamilyAnnual Review of Immunology, 2009
- Inhibition of Hydrogen Sulfide Generation Contributes to Gastric Injury Caused by Anti-Inflammatory Nonsteroidal DrugsGastroenterology, 2005
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000
- Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodentHepatology, 1997
- Inflammatory microcrystals differentially regulate the secretion of macrophage inflammatory protein 1 and interleukin 8 by human neutrophils: a possible mechanism of neutrophil recruitment to sites of inflammation in synovitis.Journal of Experimental Medicine, 1995